INFUSYSTEM HOLDINGS, INC Revenue
INFUSYSTEM HOLDINGS, INC (INFU) reported Revenue of $36.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC revenues for the quarter ending 2026-06-30 was $36.93M, a 2.59% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC revenues for the quarter ending 2026-03-31 was $33.68M, a 2.97% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC revenues for the quarter ending 2025-12-31 was $36.23M, a 7.04% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC revenues for the quarter ending 2025-09-30 was $36.49M, a 3.31% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC revenues for fiscal 2025 was $143.44M, a 6.36% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC revenues for fiscal 2024 was $134.86M, a 7.22% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC revenues for fiscal 2023 was $125.78M, a 14.44% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC revenues for fiscal 2022 was $109.91M, a 7.36% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $36.93M 10-Q · filed 2026-08-04 | $70.62M 10-Q · filed 2026-08-04 | $106.85M derived: sum of 3 quarters · filed 2026-08-04 | $143.34M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $33.68M 10-Q · filed 2026-05-08 | $69.91M derived: sum of 2 quarters · filed 2026-05-08 | $106.40M derived: sum of 3 quarters · filed 2026-05-08 | $142.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $36.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $72.72M derived: sum of 2 quarters · filed 2026-02-27 | $108.72M derived: sum of 3 quarters · filed 2026-08-04 | $143.44M 10-K · filed 2026-02-27 |
| 2025-09-30 | $36.49M 10-Q · filed 2025-11-04 | $72.49M derived: sum of 2 quarters · filed 2026-08-04 | $107.21M 10-Q · filed 2025-11-04 | $141.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $36.00M 10-Q · filed 2026-08-04 | $70.72M 10-Q · filed 2026-08-04 | $104.57M derived: sum of 3 quarters · filed 2026-08-04 | $139.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $34.72M 10-Q · filed 2026-05-08 | $68.56M derived: sum of 2 quarters · filed 2026-05-08 | $103.88M derived: sum of 3 quarters · filed 2026-05-08 | $137.58M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $33.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $69.17M derived: sum of 2 quarters · filed 2026-02-27 | $102.87M derived: sum of 3 quarters · filed 2026-02-27 | $134.86M 10-K · filed 2026-02-27 |
| 2024-09-30 | $35.32M 10-Q · filed 2025-11-04 | $69.02M derived: sum of 2 quarters · filed 2025-11-04 | $101.01M 10-Q · filed 2025-11-04 | $132.78M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $33.70M 10-Q · filed 2025-08-05 | $65.69M 10-Q · filed 2025-08-05 | $97.46M derived: sum of 3 quarters · filed 2025-08-05 | $129.37M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $32.00M 10-Q · filed 2025-05-08 | $63.77M derived: sum of 2 quarters · filed 2025-05-08 | $95.67M derived: sum of 3 quarters · filed 2025-05-08 | $127.41M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $31.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $63.68M derived: sum of 2 quarters · filed 2025-03-11 | $95.42M derived: sum of 3 quarters · filed 2025-03-11 | $125.78M 10-K · filed 2025-03-11 |
| 2023-09-30 | $31.91M 10-Q · filed 2024-11-08 | $63.64M derived: sum of 2 quarters · filed 2024-11-08 | $94.01M 10-Q · filed 2024-11-08 | $122.84M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $31.73M 10-Q · filed 2024-08-09 | $62.10M 10-Q · filed 2024-08-09 | $90.94M derived: sum of 3 quarters · filed 2024-08-09 | $118.21M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $30.37M 10-Q · filed 2024-05-09 | $59.20M derived: sum of 2 quarters · filed 2024-05-09 | $86.48M derived: sum of 3 quarters · filed 2024-05-09 | $113.52M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $28.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $56.11M derived: sum of 2 quarters · filed 2024-04-10 | $83.15M derived: sum of 3 quarters · filed 2024-04-10 | $109.91M 10-K · filed 2024-04-10 |
| 2022-09-30 | $27.28M 10-Q · filed 2023-11-09 | $54.32M derived: sum of 2 quarters · filed 2023-11-09 | $81.08M 10-Q · filed 2023-11-09 | $107.60M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $27.04M 10-Q · filed 2023-08-09 | $53.80M 10-Q · filed 2023-08-09 | $80.32M derived: sum of 3 quarters · filed 2024-04-10 | $106.89M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $26.76M 10-Q · filed 2023-05-09 | $53.28M derived: sum of 2 quarters · filed 2024-04-10 | $79.85M derived: sum of 3 quarters · filed 2024-04-10 | $104.68M derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $26.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $53.09M derived: sum of 2 quarters · filed 2024-04-10 | $77.92M derived: sum of 3 quarters · filed 2024-04-10 | $102.38M 10-K · filed 2024-04-10 |
| 2021-09-30 | $26.57M 10-Q · filed 2022-11-08 | $51.40M derived: sum of 2 quarters · filed 2022-11-08 | $75.86M 10-Q · filed 2022-11-08 | $100.57M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $24.83M 10-Q · filed 2022-08-04 | $49.30M 10-Q · filed 2022-08-04 | $74.01M derived: sum of 3 quarters · filed 2023-03-16 | $99.13M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $24.46M 10-Q · filed 2022-05-05 | $49.17M derived: sum of 2 quarters · filed 2023-03-16 | $74.30M derived: sum of 3 quarters · filed 2023-03-16 | $100.30M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $24.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $49.84M derived: sum of 2 quarters · filed 2023-03-16 | $75.83M derived: sum of 3 quarters · filed 2023-03-16 | $97.39M 10-K · filed 2023-03-16 |
| 2020-09-30 | $25.13M 10-Q · filed 2021-11-15 | $51.12M derived: sum of 2 quarters · filed 2021-11-15 | $72.68M 10-Q · filed 2021-11-15 | $94.39M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $26.00M 10-Q · filed 2021-08-12 | $47.55M 10-Q · filed 2021-08-12 | $69.26M derived: sum of 3 quarters · filed 2022-03-15 | $90.75M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $21.55M 10-Q · filed 2021-05-10 | $43.26M derived: sum of 2 quarters · filed 2022-03-15 | $64.75M derived: sum of 3 quarters · filed 2022-03-15 | $84.47M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $21.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $43.20M derived: sum of 2 quarters · filed 2022-03-15 | $62.92M derived: sum of 3 quarters · filed 2022-03-15 | $81.11M 10-K · filed 2022-03-15 |
| 2019-09-30 | $21.49M 10-Q · filed 2020-11-13 | $41.21M derived: sum of 2 quarters · filed 2020-11-13 | $59.41M 10-Q · filed 2020-11-13 | $76.97M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $19.72M 10-Q · filed 2020-08-14 | $37.92M 10-Q · filed 2020-08-14 | $55.48M derived: sum of 3 quarters · filed 2020-08-14 | $72.16M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $18.19M 10-Q · filed 2020-05-15 | $35.76M derived: sum of 2 quarters · filed 2020-05-15 | $52.43M derived: sum of 3 quarters · filed 2020-05-15 | $68.85M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $17.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $34.24M derived: sum of 2 quarters · filed 2020-03-30 | $50.66M derived: sum of 3 quarters · filed 2020-03-30 | $67.14M 10-K · filed 2020-03-30 |
| 2018-09-30 | $16.68M 10-Q · filed 2019-11-14 | $33.09M derived: sum of 2 quarters · filed 2019-11-14 | $49.58M 10-Q · filed 2019-11-14 | $68.47M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $16.41M 10-Q · filed 2019-08-14 | $32.90M 10-Q · filed 2019-08-14 | $51.79M derived: sum of 3 quarters · filed 2019-08-14 | $69.38M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $16.48M 10-Q · filed 2019-05-15 | $35.38M derived: sum of 2 quarters · filed 2019-05-15 | $52.96M derived: sum of 3 quarters · filed 2019-05-15 | $69.91M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $18.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $36.48M derived: sum of 2 quarters · filed 2019-03-22 | $53.42M derived: sum of 3 quarters · filed 2019-03-22 | $71.08M 10-K · filed 2019-03-22 |
| 2017-09-30 | $17.59M 10-Q · filed 2018-11-13 | $34.53M derived: sum of 2 quarters · filed 2018-11-13 | $52.18M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $16.94M 10-Q · filed 2018-08-14 | $34.60M 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $17.65M 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |